Does bromocriptine (dopamine agonist) cause osteoporosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Bromocriptine, a dopamine agonist medication, has not been clearly established as a direct cause of osteoporosis. While some dopamine agonists have been associated with potential bone mineral density effects, bromocriptine specifically has limited evidence linking it to significant bone loss or increased fracture risk 1. Bromocriptine is primarily used to treat conditions like hyperprolactinemia, Parkinson's disease, and sometimes type 2 diabetes at doses ranging from 1.25-20mg daily depending on the condition. The medication works by activating dopamine receptors, which reduces prolactin secretion and influences other hormonal pathways. Some studies suggest that changes in prolactin levels can potentially affect bone metabolism, but this relationship appears complex and may depend on factors like dose, duration of treatment, and individual patient characteristics.

Key points to consider:

  • The safety of bromocriptine in long-term use has been reviewed, and it appears to have no harmful effect on hepatic, renal, haematologic, or cardiac functions 1.
  • Patients taking bromocriptine who have risk factors for osteoporosis (such as postmenopausal status, long-term steroid use, or family history) should discuss bone health monitoring with their healthcare provider.
  • Routine bone density screening is not typically recommended solely based on bromocriptine use, as the current evidence does not support a strong link between bromocriptine and osteoporosis 2, 3.
  • It is essential to note that the provided evidence does not directly address the relationship between bromocriptine and osteoporosis, but rather focuses on the treatment and management of osteoporosis and steroid-induced osteoporosis 4, 5, 3.

Given the lack of direct evidence linking bromocriptine to osteoporosis, patients taking bromocriptine should focus on maintaining a healthy lifestyle, including a balanced diet and regular exercise, to support overall bone health. If concerns about osteoporosis or bone health arise, patients should consult their healthcare provider for personalized advice and guidance.

References

Research

The safety of bromocriptine in long-term use: a review of the literature.

Current medical research and opinion, 1986

Research

Side effects of drugs for osteoporosis and metastatic bone disease.

British journal of clinical pharmacology, 2019

Research

What is new in the treatment of steroid-induced osteoporosis?

Seminars in cutaneous medicine and surgery, 2006

Research

Glucocorticoid-induced osteoporosis: treatment update and review.

Therapeutic advances in musculoskeletal disease, 2009

Research

Compliance with drug therapy for postmenopausal osteoporosis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2006

Related Questions

What is the fracture risk category for a patient with a history of hypertension, kidney transplantation, and hyperlipidemia, taking prednisone (corticosteroid) 5 mg daily, with dual-energy X-ray absorptiometry (DXA) scan T-scores and FRAX estimates, according to the American College of Rheumatology guideline for glucocorticoid-induced osteoporosis?
What is the recommended dosage and usage of Bromocryptine (Bromocriptine) for treating Parkinson's disease and hyperprolactinemia?
What is the recommended dosage of bromocriptine (dopamine agonist)?
Can a patient with osteoporosis be excused from jury duty if it conflicts with her scheduled monthly injections for comprehensive osteoporosis treatment, such as denosumab (Prolia) or zoledronic acid (Reclast), over the next 10 months?
Should a 60-year-old woman with osteopenia start bisphosphonate medication and stop Hormone Replacement Therapy (HRT)?
What is not an appropriate first-line therapy for an immunocompetent patient diagnosed with Herpes Simplex Virus 1 (HSV-1) infection gingivostomatitis?
What is the dosing for Zosyn (piperacillin-tazobactam) in patients with impaired renal function?
What is the most appropriate first-line therapy for a patient with approximately 7% of their Body Surface Area (BSA) affected by plaque psoriasis?
What is the recommended dose for benzyl penicillin (Penicillin G) in patients with impaired renal function?
What therapy should be ordered to inhibit toxin production in a patient with necrotizing fasciitis caused by Streptococcus (S.) Pyogenes?
What is the function of the loop of Henle in the nephron?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.